ProSAAS-mediated neuroprotective mechanisms in Alzheimer's and Parkinson's diseases: the role of secretory chaperones in neurodegeneration
ProSAAS 介导的阿尔茨海默病和帕金森病的神经保护机制:分泌伴侣在神经退行性变中的作用
基本信息
- 批准号:10532769
- 负责人:
- 金额:$ 63.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-01 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAffectAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease related dementiaAmericanAmyloidAmyloid beta-ProteinAmyloid depositionAnimal ModelAttenuatedBiochemicalBlood VesselsBrainCell LineCell modelCellsClientCorpus striatum structureCoupledCultured CellsCytopathologyCytoplasmic GranulesCytoprotectionDepositionDevelopmentDiseaseDisease modelDopamineEndocrineExhibitsFrequenciesHealthHealthcare SystemsHippocampusHomeostasisIn VitroIndividualLaboratoriesLocationMaintenanceMediatingMidbrain structureModelingMolecular ChaperonesMotorNerve DegenerationNeurodegenerative DisordersNeuronsParkinson DiseasePathogenicityPathologyPathway interactionsPatientsPeptidesPeriodicityPick Disease of the BrainPlayProcessProteinsProteomicsRattusRoleScanningSenile PlaquesSiteSpeedSubstantia nigra structureSynapsesSynaptic VesiclesTestingToxic effectTyrosine 3-MonooxygenaseViralWorkabeta accumulationalpha synucleinamyloid pathologybrain tissuecytotoxiccytotoxicitydifferential expressiondopaminergic neuronexperimental studyextracellularimmunoreactivityin vivoin vivo Modelinhibitorinsightknock-downloss of functionmouse modelneuron lossneuroprotectionneurotoxicneurotoxicityolder patientoverexpressionpotential biomarkerpre-formed fibrilprotein aggregationproteostasissmall hairpin RNAunpublished works
项目摘要
Demographic considerations predict an overwhelming burden on the U.S. health care system within
the next few decades due to an influx of elderly patients with neurodegenerative disease. The most
prevalent of these, Alzheimer's and Parkinson's diseases (AD and PD), are predicted to affect tens of
millions of Americans by 2040. Both of these diseases involve progressively more aberrant brain
proteostasis, associated with massive neuronal cell death. A variety of cytosolic and secreted brain
chaperones contribute to maintenance of neuronal proteostasis in these and other neurodegenerative
proteinopathies; of these, the secretory chaperone proSAAS has many compelling features. ProSAAS is
expressed only in neurons and endocrine cells; because it traffics through the regulated secretory
pathway, it becomes concentrated within dense core synaptic granules, and is released during neuronal
activity. ProSAAS has been identified by five proteomics groups as a potential biomarker in
neurodegenerative disease, and is found associated with aggregated proteins in the substantia nigra of
PD patients as well as with amyloid plaques in AD‐affected individuals. ProSAAS blocks the
aggregation of both Abeta and alpha synuclein at highly substoichiometric ratios, and both
endogenous overexpression as well as exogenous application reduce Abeta‐ and alpha synuclein‐mediated neurotoxicity in primary neurons and cell lines. Most recently, we have shown that proSAAS
overexpression is also functionally protective in vivo in a rat model of alpha‐synuclein overexpression.
In the proposed work, we will investigate the likely common mechanisms by which proSAAS
protects neurons from neurotoxic aggregating proteins and peptides such as alpha synuclein and Abeta
1‐42. We hypothesize that secreted proSAAS sequesters cytotoxic oligomers and fibrils extracellularly,
reducing their concentrations at the synapse. Secondly, we hypothesize that endocytosed proSAAS acts
intracellularly to similarly sequester cytotoxic proteins, speeding their degradation. Using cultured
primary hippocampal and nigral neurons, we will determine whether proSAAS is involved in
intracellular and extracellular Abeta and alpha synuclein sequestration. We will also determine
whether intracellular expression of proSAAS confers a cytoprotective advantage compared to
extracellular addition. Lastly we will assess whether endocytosed proSAAS accelerates the intracellular
degradation of Abeta and alpha synuclein.
In parallel, we will expand our exciting in vivo results to include the alpha‐synuclein preformed
fibril model to tease apart the potential sites of action of proSAAS in substantia nigra and striatum. Pre‐degenerative changes in dopamine homeostasis, assessed using fast‐scan‐cyclic‐voltammetry, will be
correlated with proSAAS‐mediated neuroprotection. Similarly, a mouse model of AD will be used to
test the effects of proSAAS AAV‐mediated over‐ and underexpression on the development of amyloid
pathology. Collectively, these experiments will provide insight into biochemical mechanisms
underlying the potent cytoprotective effects of the proSAAS chaperone protein.
人口统计学因素预测,美国医疗保健系统将承受巨大负担,
未来几十年,由于大量老年神经退行性疾病患者的涌入。最
其中流行的阿尔茨海默病和帕金森病(AD和PD)预计将影响数十名
到2040年将有数百万美国人。这两种疾病都涉及越来越多的异常大脑
蛋白质稳态,与大量神经元细胞死亡有关。各种细胞质和分泌的脑
分子伴侣有助于维持这些和其他神经退行性疾病中的神经元蛋白质稳态,
蛋白质病;其中,分泌型伴侣蛋白proSAAS具有许多引人注目的特征。ProSAAS是
仅在神经元和内分泌细胞中表达;因为它通过受调节的分泌细胞运输,
在神经传导通路中,它集中在致密的核心突触颗粒内,并在神经元传导过程中释放。
活动ProSAAS已被五个蛋白质组学小组确定为一种潜在的生物标志物,
神经退行性疾病,并发现与黑质中的聚集蛋白有关,
PD患者以及AD患者中的淀粉样斑块。ProSAAS阻止了
A β和α突触核蛋白以高度亚化学计量比聚集,
内源性过表达以及外源性应用降低了原代神经元和细胞系中Abeta和alpha突触核蛋白介导的神经毒性。最近,我们已经表明,proSAAS
过表达在α-突触核蛋白过表达的大鼠模型中也具有体内功能保护性。
在拟议的工作中,我们将调查proSAAS可能的共同机制,
保护神经元免受神经毒性聚集蛋白质和肽如α突触核蛋白和Abeta
1-42我们假设分泌的proSAAS在细胞外螯合细胞毒性寡聚体和原纤维,
降低了它们在突触处的浓度。其次,我们假设内吞的proSAAS作用于
细胞内类似地螯合细胞毒性蛋白,加速其降解。使用培养
原代海马和黑质神经元,我们将确定proSAAS是否参与
细胞内和细胞外A β和α突触核蛋白隔离。我们还将确定
proSAAS的细胞内表达是否赋予细胞保护优势,
胞外添加最后,我们将评估内吞的proSAAS是否加速了细胞内
A β和α突触核蛋白的降解。
与此同时,我们将扩大我们令人兴奋的体内结果,包括α-突触核蛋白预先形成
原纤维模型梳理除了黑质和纹状体中的proSAAS的潜在作用位点。将使用快速扫描循环伏安法评估多巴胺稳态的退行性前变化,
与proSAAS介导的神经保护作用相关。类似地,AD的小鼠模型将用于
检测proSAAS AAV介导的过度表达和低表达对淀粉样蛋白形成的影响,
病理总的来说,这些实验将提供深入了解生化机制
潜在的proSAAS伴侣蛋白的有效的细胞保护作用。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Increased expression and retention of the secretory chaperone proSAAS following cell stress.
- DOI:10.1007/s12192-020-01128-7
- 发表时间:2020-11
- 期刊:
- 影响因子:3.8
- 作者:Shakya M;Yildirim T;Lindberg I
- 通讯作者:Lindberg I
A protease protection assay for the detection of internalized alpha-synuclein pre-formed fibrils.
- DOI:10.1371/journal.pone.0241161
- 发表时间:2021
- 期刊:
- 影响因子:3.7
- 作者:Jarvela TS;Chaplot K;Lindberg I
- 通讯作者:Lindberg I
The proSAAS Chaperone Provides Neuroprotection and Attenuates Transsynaptic α-Synuclein Spread in Rodent Models of Parkinson's Disease.
- DOI:10.3233/jpd-213053
- 发表时间:2022
- 期刊:
- 影响因子:5.2
- 作者:Lindberg, Iris;Shu, Zhan;Lam, Hoa;Helwig, Michael;Yucer, Nur;Laperle, Alexander;Svendsen, Clive N.;Di Monte, Donato A.;Maidment, Nigel T.
- 通讯作者:Maidment, Nigel T.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IRIS LINDBERG其他文献
IRIS LINDBERG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IRIS LINDBERG', 18)}}的其他基金
ProSAAS-mediated neuroprotective mechanisms in Alzheimer's and Parkinson's diseases: the role of secretory chaperones in neurodegeneration
ProSAAS 介导的阿尔茨海默病和帕金森病的神经保护机制:分泌伴侣在神经退行性变中的作用
- 批准号:
10327703 - 财政年份:2019
- 资助金额:
$ 63.37万 - 项目类别:
ProSAAS-mediated neuroprotective mechanisms in Alzheimer's and Parkinson's diseases: the role of secretory chaperones in neurodegeneration
ProSAAS 介导的阿尔茨海默病和帕金森病的神经保护机制:分泌伴侣在神经退行性变中的作用
- 批准号:
10062465 - 财政年份:2019
- 资助金额:
$ 63.37万 - 项目类别:
The Secretory Chaperone 7B2 as an Endogenous Regulator of Amyloid Pathology
分泌伴侣 7B2 作为淀粉样蛋白病理学的内源性调节剂
- 批准号:
8568474 - 财政年份:2014
- 资助金额:
$ 63.37万 - 项目类别:
The Secretory Chaperone 7B2 as an Endogenous Regulator of Amyloid Pathology
分泌伴侣 7B2 作为淀粉样蛋白病理学的内源性调节剂
- 批准号:
8919199 - 财政年份:2014
- 资助金额:
$ 63.37万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 63.37万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 63.37万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 63.37万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 63.37万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 63.37万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 63.37万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 63.37万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 63.37万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 63.37万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 63.37万 - 项目类别:
Grant-in-Aid for Early-Career Scientists